23andMe — the struggling DNA company once valued in the billions — was essentially worthless as of Wednesday.
But in a filing late Wednesday, Anne Wojcicki revealed she wants to buy back the company she cofounded in 2006 and take it private.
On Saturday, Wojcicki notified board members of her plans to acquire all outstanding shares in the company, indicating that “she was working with advisors and plans to begin speaking to potential partners and financing sources,” according to an SEC filing.
The filing states Wojcicki wants to retain control of the company and “will not be willing to support any alternative transaction.”
23andMe confirmed it was aware of Wojcicki’s plans in a press releaseThursday. It said its board formed a Special Committee on March 28 and would review Wojcicki’s proposal “when and if it is made available and evaluate it in light of other available strategic alternatives, including continuing to operate as a publicly traded …